Personal profile

Research interests

My research interest is developing new therapeutic agents for pancreatic cancer. The mammalian target of rapamycin (mTOR) is a downstream mediator in the phosphatidylinositol 3-kinase (PI3K) pathway that regulates cell proliferation, cell survival and angiogenesis in cancer. We hypothesize that combined blockade of the converging pathways can yield a better anti-tumor activity. Currently, we are in the process of examining the clinical benefit of double blockade with a phase I clinical study of the mTOR inhibitor and the EGFR inhibitor in recurrent/refractory malignancies. Furthermore, we are evaluating the potential predictive factors for treatment response and exploring the mechanism of treatment resistance.

Clinical interests

gastrointestinal cancer, pancreatic cancer


Dive into the research topics where Andrea Wang-Gillam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or